Neuroptika
Cambridge
About Neuroptika
Neuroptika’s mission is to improve patients’ lives by developing novel regenerative therapies for ophthalmic diseases
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Last round: Series Unknown (Jan 2020)
- Website: neuroptika.com
Industries & Categories
Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/neuroptika-2817573 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.